MediciNova, Inc. (MNOV)
MediciNova, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
MediciNova, Inc. (MNOV) is a Biotechnology company based in US with a market capitalization of $65.5M. Free cash flow was negative at -$9.8M. This page tracks MNOV's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 13 employees · IPO Dec 8, 2006
Valuation
Valuation & price
$1.38as of May 17, 2026· -26.6% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
1.57
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$65.5M
Market cap
—
Revenue growth (YoY)
7.6%
Gross margin
-$9.8M
Free cash flow (USD)
-$30.6M
Net debt
Net cash position
0.0%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 15, 2026 (EPS $-0.05)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is MediciNova, Inc.'s market cap?
MediciNova, Inc. (MNOV) has a market capitalization of $65.5M.
What is MNOV's P/E ratio?
A meaningful P/E ratio is not available for MNOV — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is MNOV's price-to-book (P/B) ratio?
MNOV trades at 1.57 times book value per share.
When did MediciNova, Inc. last report earnings?
MNOV last reported earnings on May 15, 2026; the next date is not yet scheduled.
Are insiders buying MNOV stock?
SEC Form 4 filings show no open-market insider buys at MediciNova, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.